STATE STREET CORP - CLARUS THERAPEUTICS HLDNGS I ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$10,00025,5360.00%
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q3 2023
NameSharesValueWeighting ↓
Bracebridge Capital, LLC 2,002,495$761,0000.12%
SABBY MANAGEMENT, LLC 200,000$76,0000.05%
Ayrton Capital LLC 32,525$12,0000.02%
Powell Investment Advisors, LLC 60,000$23,0000.01%
Virtu Financial LLC 188,086$72,0000.01%
Warberg Asset Management LLC 55,000$21,0000.01%
UBS Group AG 23,534$9,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 45,000$17,0000.00%
Squarepoint Ops LLC 29,085$11,0000.00%
TWO SIGMA INVESTMENTS, LP 10,001$4,0000.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders